- Home
- MAN vs CERT Comparison
MAN vs CERT Comparison
Compare MAN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAN | CERT |
|---|---|---|
| Founded | 1948 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAN | CERT |
|---|---|---|
| Price | $29.23 | $7.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $39.67 | $12.22 |
| AVG Volume (30 Days) | 1.5M | ★ 3.3M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | ★ 5.02% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,957,100,000.00 | $418,838,000.00 |
| Revenue This Year | $5.26 | $5.05 |
| Revenue Next Year | $3.34 | $5.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.58 | ★ 8.75 |
| 52 Week Low | $25.15 | $6.04 |
| 52 Week High | $63.35 | $15.38 |
Technical Indicators
Market Signals| Indicator | MAN | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 41.24 |
| Support Level | $28.26 | $6.04 |
| Resistance Level | $29.26 | $11.53 |
| Average True Range (ATR) | 1.57 | 0.40 |
| MACD | 0.09 | 0.14 |
| Stochastic Oscillator | 78.09 | 64.87 |
Price Performance
Historical ComparisonAbout MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.